Hemovigilance: clinical tolerance of solvent-detergent treated plasma.

@article{Baudoux1998HemovigilanceCT,
  title={Hemovigilance: clinical tolerance of solvent-detergent treated plasma.},
  author={Etienne Baudoux and U Margraff and Amy Coenen and X Jacobs and M Strivay and Cordrin Lungu and Daniel Sondag-Thull},
  journal={Vox sanguinis},
  year={1998},
  volume={74 Suppl 1},
  pages={237-9}
}
OBJECTIVE This study was conducted to assess retrospectively the clinical tolerance of SD treated plasma and to compare it to other labile blood products (red blood cell and platelet concentrates). METHODS Adverse events (AEs) related to the use of blood products at the Blood Transfusion Center (BTC) are routinely collected through a formalised system of hemovigilance. All AEs reported are entered into a safety data base which was used for the study. All AEs reported during a one-year period… CONTINUE READING
7 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Similar Papers

Loading similar papers…